Although the oncogenic functions of FOXA1 have been extensively studied in breast and prostate cancer, its potential role in regulating cancer-specific transcriptional programs in other tumor lineages is just beginning to be appreciated. This evidence concerns the gene FOXA1 and prostate carcinoma.